Early Access to Cabazitaxel in Patients With Metastatic Hormone Refractory Prostate Cancer Previously Treated With a Docetaxel-containing Regimen
Condition: Prostate Cancer MetastaticIntervention: Drug: CABAZITAXELSponsor: SanofiActive, not recruiting - verified January 2015
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Docetaxel | Hormone Refractory Prostate Cancer | Hormones | Prostate Cancer | Research | Taxotere